Puissance Life Science Opportunities Fund VI

10% owner at Bellerophon Therapeutics, Inc.

Sold, on record
$108k
Dollars the filings state
Form 4 sales
1
Latest Oct 13, 2023
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice Bellerophon Therapeutics, Inc.Notice
    May 18, 2023 2023

    Filed to sell 560,000 shares ($5.3M)

    Puissance Life Science Opportunities Fund VI, 10% Stockholder

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice Bellerophon Therapeutics, Inc.Notice
    Jun 7, 2023 +20 days

    Filed to sell 134,421 shares ($111k)

    Puissance Life Science Opportunities Fund VI, 10% Stockholder

    10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale Bellerophon Therapeutics, Inc.Unusual
    Oct 13, 2023 +128 days

    Sold 1.1M shares at $0.10 ($108k)

    Puissance Life Science Opportunities Fund VI, 10% owner

    No 10b5-1 planSold 100% of holdings ($108k position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Puissance Life Science Opportunities Fund VI
Source
Oct 13, 2023Oct 16, 2023Bellerophon Therapeutics, Inc.10% ownerForm 4 sale1.1M$108k100.0%UnusualSEC
Jun 7, 2023Jun 7, 2023Bellerophon Therapeutics, Inc.10% StockholderForm 144 notice134,421$111kNoticeSEC
May 18, 2023May 18, 2023Bellerophon Therapeutics, Inc.10% StockholderForm 144 notice560,000$5.3MNoticeSEC